Literature DB >> 21516570

On sample size determination in multi-armed confirmatory adaptive designs.

Gernot Wassmer1.   

Abstract

An important application of confirmatory adaptive designs is the data-driven selection of treatment arms in multi-armed trials. A general methodology for adaptive designs is based on the combination testing principle. Using this principle, selection of treatment arms in multi-armed designs, recalculation of sample size, and more general data-driven changes to the design are possible without undermining type I error control. In this paper we consider aspects related to the sample size determination for multi-armed designs. We assess sample size calculations that are based on ad hoc formulas such as the Bonferroni correction. An important aspect will be the choice of the control group sample size. We further consider the weighting scheme in the combination testing approach. Our assessment is restricted to two-stage designs. In general, simulation tools will be necessary to assess the statistical properties of these designs.

Mesh:

Year:  2011        PMID: 21516570     DOI: 10.1080/10543406.2011.551336

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  6 in total

1.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

2.  ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.

Authors:  Tarun Chakravarty; Raj R Makkar; Deborah D Ascheim; Jay H Traverse; Richard Schatz; Anthony DeMaria; Gary S Francis; Thomas J Povsic; Rachel R Smith; Joao A Lima; Janice M Pogoda; Linda Marbán; Timothy D Henry
Journal:  Cell Transplant       Date:  2016-08-18       Impact factor: 4.064

3.  A simple and flexible graphical approach for adaptive group-sequential clinical trials.

Authors:  Toshifumi Sugitani; Frank Bretz; Willi Maurer
Journal:  J Biopharm Stat       Date:  2014-11-05       Impact factor: 1.051

4.  Planning multi-arm screening studies within the context of a drug development program.

Authors:  James M S Wason; Thomas Jaki; Nigel Stallard
Journal:  Stat Med       Date:  2013-03-26       Impact factor: 2.373

5.  Some recommendations for multi-arm multi-stage trials.

Authors:  James Wason; Dominic Magirr; Martin Law; Thomas Jaki
Journal:  Stat Methods Med Res       Date:  2012-12-12       Impact factor: 3.021

6.  Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.

Authors:  Nigel Stallard; Lisa Hampson; Norbert Benda; Werner Brannath; Thomas Burnett; Tim Friede; Peter K Kimani; Franz Koenig; Johannes Krisam; Pavel Mozgunov; Martin Posch; James Wason; Gernot Wassmer; John Whitehead; S Faye Williamson; Sarah Zohar; Thomas Jaki
Journal:  Stat Biopharm Res       Date:  2020-07-29       Impact factor: 1.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.